- Global Pharma News & Resources

South Africa E-Cigarette Regulation Report, Q2 2022 Update -

DUBLIN--(BUSINESS WIRE)--The "South Africa: E-Cigarette Regulation, June 2022" report has been added to's offering.

This report offers a detailed overview of the current regulatory framework in place for e-cigs and related products in South Africa, covering all policy areas from taxation and notification to advertising, labelling and packaging, and retail channel restrictions.

E-cigarette products with nicotine are subject to the pharmaceutical regime in South Africa as nicotine is a scheduled drug under the Medicines and Related Substances Act.

However, in practice, e-cigarette products with nicotine are widely available on the black market due to weak law enforcement. Despite industry efforts, the 2018 bill to regulate nicotine-containing and nicotine-free e-cigarettes is unlikely to be passed in 2022, as it has not yet been tabled.

Key Topics Covered:

1 Executive Summary

2 Outlook

3 South Africa: The Basics

4 National Regulatory Framework

5 Age Restrictions

6 Product Restrictions

7 Labelling and Packaging

8 Obligation to Notify

9 Retail Restrictions

10 Public Usage

11 Advertising and Marketing

12 Taxation

13 Enforcement

14 Case Law

15 Relevant Law

16 Relevant Bodies and Organisation

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 06-Oct-2022